$EVAX

$3.63▲ -2.2% YTD

4 SEC 13D/G filings tracked · Last updated Oct 23, 2026

Filing History

CP $3.63▲ -2.2%Oct 23, 2026 · ThinkSabio Blog

$EVAX - Evaxion announces 89% vaccine target precision and sustained T-cell and clinical responses at three-year follow-up in phase 2 trial with perso…

News

EVAX ▲ +15.7% - Evaxion A/S

CP $3.25▲ +15.7%Oct 19, 2026 · ThinkSabio Blog

$EVAX - Evaxion reports sustained clinical responses for all patients at three-year follow-up in phase 2 trial with personalized cancer vaccine EVX-01…

News

EVAX ▲ +4.1% - Evaxion A/S

CP $3.28▲ +4.1%Oct 2, 2026 · ThinkSabio Blog

$EVAX - Evaxion will present new immune data for personalized cancer vaccine EVX-01 at the SITC 2026 Annual Meeting…

News

EVAX ▲ +1.9% - Evaxion A/S

CP $3.19▲ +1.9%Sep 14, 2026 · ThinkSabio Blog

$EVAX - Evaxion applies its AI-Immunology™ platform in autoimmune diseases…